2022 Senate Bill 994 ↩

House Roll Call 209: Passed

To create a 24-member “opioid advisory commission” within the Legislative Council, a bipartisan entity that administers the legislative branch of state government. This would be comprised of specified political appointees and state officials, and would provide annual reviews of state government’s activities in this area. This would be in addition to a separate “Prescription Drug and Opioid Abuse Commission” in the Department of Licensing and Regulatory Affairs, which itself replaced an earlier Controlled Substances Advisory Commission, and an Advisory Committee on Pain and Symptom Management.